Use of energy device in general surgical operations: impact on peri-operative outcomes.
Devices
Energy
Ligasure
Journal
BMC surgery
ISSN: 1471-2482
Titre abrégé: BMC Surg
Pays: England
ID NLM: 100968567
Informations de publication
Date de publication:
09 Mar 2022
09 Mar 2022
Historique:
received:
10
05
2021
accepted:
07
02
2022
entrez:
10
3
2022
pubmed:
11
3
2022
medline:
12
3
2022
Statut:
epublish
Résumé
The introduction of energy devices has significantly expanded the scope of surgical expedition. The LigaSure™ vessel sealing system is a bipolar electrosurgical device, recently introduced to our practice. Its impact on peri-operative outcomes in a variety of major operations was evaluated in this study. A retrospective review of operations performed following the adoption of the LigaSure™ vessel sealing device was carried out. Five categories of operations were evaluated (Thyroidectomies, Gastrectomies, Colectomies, Pancreaticoduodenectomies, and Anterior/Abdomino-perineal resection [A/APR of the rectum). Peri-operative outcomes (duration of operation, intra-operative blood loss, blood transfusion rates) were compared with a cohort of similar operations performed using conventional techniques. Data analysis and comparisons were done on a subgroup basis. A total of 117 operations were performed using the LigaSure™ device with thyroidectomies being the most common (66/117-56.4%). Compared to cases done using conventional techniques of suture and knot with electrocautery (120 cases), the use of LigaSure™ was associated with a significant reduction in operation time in all categories of operations. Intraoperative blood loss was also lower in all categories of cases, but this was only statistically significant following A/APR and Thyroidectomies. Generally, there was a trend towards a reduction in blood transfusion rates. The use of energy devices for surgical operations is feasible in a resource-limited setting. It has the potential of improving outcomes.
Sections du résumé
BACKGROUND
BACKGROUND
The introduction of energy devices has significantly expanded the scope of surgical expedition. The LigaSure™ vessel sealing system is a bipolar electrosurgical device, recently introduced to our practice. Its impact on peri-operative outcomes in a variety of major operations was evaluated in this study.
METHODS
METHODS
A retrospective review of operations performed following the adoption of the LigaSure™ vessel sealing device was carried out. Five categories of operations were evaluated (Thyroidectomies, Gastrectomies, Colectomies, Pancreaticoduodenectomies, and Anterior/Abdomino-perineal resection [A/APR of the rectum). Peri-operative outcomes (duration of operation, intra-operative blood loss, blood transfusion rates) were compared with a cohort of similar operations performed using conventional techniques. Data analysis and comparisons were done on a subgroup basis.
RESULTS
RESULTS
A total of 117 operations were performed using the LigaSure™ device with thyroidectomies being the most common (66/117-56.4%). Compared to cases done using conventional techniques of suture and knot with electrocautery (120 cases), the use of LigaSure™ was associated with a significant reduction in operation time in all categories of operations. Intraoperative blood loss was also lower in all categories of cases, but this was only statistically significant following A/APR and Thyroidectomies. Generally, there was a trend towards a reduction in blood transfusion rates.
CONCLUSIONS
CONCLUSIONS
The use of energy devices for surgical operations is feasible in a resource-limited setting. It has the potential of improving outcomes.
Identifiants
pubmed: 35264141
doi: 10.1186/s12893-022-01540-z
pii: 10.1186/s12893-022-01540-z
pmc: PMC8908598
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
90Informations de copyright
© 2022. The Author(s).
Références
Am J Surg. 2011 Feb;201(2):166-70
pubmed: 20864081
Surg Innov. 2008 Dec;15(4):284-91
pubmed: 18945705
Arch Surg. 2012 Jan;147(1):49-55
pubmed: 22250113
Surg Today. 2014 Sep;44(9):1723-9
pubmed: 24838660
Surg Endosc. 2013 Sep;27(9):3056-72
pubmed: 23609857
J Am Coll Surg. 2006 Mar;202(3):520-30
pubmed: 16500257
Surg Today. 2010 Nov;40(11):1050-4
pubmed: 21046504
Asian J Endosc Surg. 2014 May;7(2):95-101
pubmed: 24754878
J Laparoendosc Adv Surg Tech A. 2012 Jul-Aug;22(6):572-7
pubmed: 22458835
Niger J Surg. 2019 Jan-Jun;25(1):64-69
pubmed: 31007515
JAMA Surg. 2015 Feb;150(2):110-7
pubmed: 25472485
Scand J Surg. 2020 Jun;109(2):151-158
pubmed: 30760107
Am J Surg. 2008 Jan;195(1):48-52
pubmed: 18082542
Gastric Cancer. 2015 Oct;18(4):843-9
pubmed: 25129120
Minerva Chir. 2010 Jun;65(3):251-8
pubmed: 20668414
Surg Endosc. 2001 Aug;15(8):799-801
pubmed: 11443443
Sci Rep. 2017 Aug 23;7(1):9221
pubmed: 28835620
Anesthesiology. 2011 Feb;114(2):283-92
pubmed: 21239971
World J Gastrointest Surg. 2012 Jan 27;4(1):1-8
pubmed: 22347536
Surg Endosc. 2012 Oct;26(10):2892-901
pubmed: 22538684
Eur Arch Otorhinolaryngol. 2018 May;275(5):1257-1263
pubmed: 29536251
HPB (Oxford). 2013 Oct;15(10):747-52
pubmed: 23782268
World J Surg Oncol. 2018 Jun 1;16(1):101
pubmed: 29859101
Surg Endosc. 1998 Jun;12(6):876-8
pubmed: 9602010
Surg Infect (Larchmt). 2017 Aug/Sep;18(6):722-735
pubmed: 28832271